The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Celgene
Consulting or Advisory Role - Celgene
Phase I evaluation of the PI3 kinase (PI3K) inhibitor taselisib (GDC-0032) in multiple locally advanced or metastatic PIK3CA mutant solid tumor types.
 
Komal L. Jhaveri
Consulting or Advisory Role - Dara Biosciences; Genentech; Samus Therapeutics
 
Philippe L. Bedard
Consulting or Advisory Role - Genentech/Roche (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Oncothyreon (Inst); PTC Therapeutics (Inst); Sanofi (Inst); SERVIER (Inst); SignalChem (Inst)
 
Juan Miguel Cejalvo
No Relationships to Disclose
 
Lowell L. Hart
Speakers' Bureau - Boehringer Ingelheim; Genentech; Novartis
Research Funding - Florida Cancer Specialists
 
Dejan Juric
Research Funding - Novartis
 
Karen Kelly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Lilly; Synta
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Genentech (Inst); Gilead Sciences (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Synta (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Lilly; Roche; Synta
 
A. Craig Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Teva (Inst)
 
Anton Melnyk
No Relationships to Disclose
 
Kathleen N. Moore
Consulting or Advisory Role - Advaxis; Amgen (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Immunogen (Inst); Merrimack
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; Baxalta; Takeda
 
Mafalda Oliveira
Research Funding - AstraZeneca
 
Manish R. Patel
Honoraria - Gilead Sciences; Medivation; Taiho Pharmaceutical
Speakers' Bureau - Gilead Sciences; Medivation; Taiho Pharmaceutical
 
Jasgit Sachdev
No Relationships to Disclose
 
David Smith
Employment - US Oncology
 
Ari VanderWalde
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caris Life Sciences
Research Funding - Amgen; AstraZeneca; Genentech; Lilly; Merck; Millennium; Polynoma
 
Joseph A. Ware
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
Travel, Accommodations, Expenses - Genentech
 
Huan Jin
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Timothy R. Wilson
Employment - Genentech
Stock and Other Ownership Interests - Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Michael C Wei
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Sanofi
 
Jose Baselga
Stock and Other Ownership Interests - Apogenix; Infinity Pharmaceuticals; Juno Therapeutics; PMV Pharma
Consulting or Advisory Role - Infinity Pharmaceuticals; Juno Therapeutics; Lilly; PMV Pharma
Travel, Accommodations, Expenses - Novartis; Roche/Genentech